Abi-Dargham, A, Gil, R, Krystal, J, Baldwin, RM, Seibyl, JP, Bowers, M, Van Dyck, CH, Charney, DS, Innis, RB, Laruelle, M (1998). Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. American Journal of Psychiatry
Andersen, TF, Madsen, M, Jørgensen, J, Mellemkjoer, L, Olsen, JH (1999). The Danish National Hospital Register. A valuable source of data for modern health sciences. Danish Medical Bulletin
Bhattacharyya, S, Fusar-Poli, P, Borgwardt, S, Martin-Santos, R, Nosarti, C, O'Carroll, C, Allen, P, Seal, ML, Fletcher, PC, Crippa, JA, Giampietro, V, Mechelli, A, Atakan, Z, McGuire, P (2009). Modulation of mediotemporal and ventrostriatal function in humans by Δ9-tetrahydrocannabinol. Archives of General Psychiatry
Callaghan, RC, Cunningham, JK, Allebeck, P, Arenovich, T, Sajeev, G, Remington, G, Boileau, I, Kish, SJ (2012). Methamphetamine use and schizophrenia: a population-based cohort study in California. American Journal of Psychiatry
Curran, C, Byrappa, N, McBride, A (2004). Stimulant psychosis: systematic review. British Journal of Psychiatry
EMCDDA (2015). European Drug Report 2015. Trends and developments. European Monitoring Centre for Drugs and Drug Addiction.
EMCDDA (2011). Annual report 2011. The state of the drugs problem in Europe. European Monitoring Centre for Drugs and Drug Addiction, p. 112.
Gurillo, P, Jauhar, S, Murray, RM, MacCabe, JH (2015). Does tobacco use cause psychosis? Systematic review and meta-analysis. Lancet Psychiatry
Howes, OD, Kambeitz, J, Kim, E, Stahl, D, Slifstein, M, Abi-Dargham, A, Kapur, S (2012). The nature of dopamine dysfunction in schizophrenia and what this means for treatment. Archives of General Psychiatry
Janowsky, DS, Risch, C (1979). Amphetamine psychosis and psychotic symptoms. Psychopharmacology
Jordaan, GP, Emsley, R (2014). Alcohol-induced psychotic disorder: a review. Metabolic Brain Disease
Jordaan, GP, Warwick, JM, Nel, DG, Hewlett, R, Emsley, R (2012). Alcohol-induced psychotic disorder: brain perfusion and psychopathology – before and after antipsychotic treatment. Metabolic Brain Disease
Kildemoes, HW, Sørensen, HT, Hallas, J (2011). The Danish National Prescription Registry. Center for Healthy Ageing, Department of Public Health, University of Copenhagen, Denmark. Scandinavian Journal of Public Health
Koskinen, J, Löhönen, J, Koponen, H, Isohanni, M, Miettunen, J, Lohonen, J, Koponen, H, Isohanni, M, Miettunen, J (2010). Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis. Schizophrenia Bulletin
Kuepper, R, van Os, J, Lieb, R, Wittchen, H-U, Höfler, M, Henquet, C (2011). Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study. British Medical Journal (Clinical Research Edition)
Macleod, J, Oakes, R, Copello, A, Crome, I, Egger, M, Hickman, M, Oppenkowski, T, Stokes-Lampard, H, Davey Smith, G (2004). Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies. Lancet
Menezes, P, Busatto, G, McGuire, P, Murray, R, Scazufca, M (2016). Tobacco smoking and risk of first episode psychosis: a case-control study in Sao Paulo, Brazil. Schizophrenia (Supplement), T126. Abstracts from the 5th Biennial SIRS Conference.
Moore, THM, Zammit, S, Lingford-Hughes, A, Barnes, TRE, Jones, PB, Burke, M, Lewis, G (2007). Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet
Mors, O, Perto, GP, Mortensen, PB (2011). The Danish Psychiatric Central Research Register. Scandinavian Journal of Public Health
Myles, N, Newall, HD, Curtis, J, Nielssen, O, Shiers, D, Large, M (2012). Tobacco use before, at, and after first-episode psychosis: a systematic meta-analysis. Journal of Clinical Psychiatry
Okaneku, J, Vearrier, D, McKeever, RG, LaSala, GS, Greenberg, MI (2015). Change in perceived risk associated with marijuana use in the United States from 2002 to 2012. Clinical Toxicology
van Os, J, Kapur, S (2009). Schizophrenia. Lancet
van Os, J, Kenis, G, Rutten, BPF (2010). The environment and schizophrenia. Nature
Pedersen, CB, Gøtzsche, H, Møller, JO, Mortensen, PB (2006). The Danish Civil Registration System. A cohort of eight million persons. Danish Medical Bulletin
Pedersen, CB, Mors, O, Bertelsen, A, Waltoft, BL, Agerbo, E, McGrath, JJ, Mortensen, PB, Eaton, WW (2014). A comprehensive nationwide study of the incidence rate and lifetime risk for treated mental disorders. JAMA Psychiatry
Power, Ra, Verweij, KJH, Zuhair, M, Grant, W, Henders, AK, Heath, AC, Madden, PaF, Medland, SE, Wray, NR, Martin, NG (2015). Genetic predisposition to schizophrenia associated with increased use of cannabis. Molecular Psychiatry
Salavati, B, Rajji, TK, Price, R, Sun, Y, Graff-Guerrero, A, Daskalakis, ZJ (2015). Imaging-based neurochemistry in Schizophrenia: a systematic review and implications for Dysfunctional long-term potentiation. Schizophrenia Bulletin
Satel, SL, Edell, WS (1991). Cocaine-induced paranoia and psychosis proneness. American Journal of Psychiatry
Toftdahl, NG, Nordentoft, M, Hjorthøj, C (2015). Prevalence of substance use disorders in psychiatric patients: a nationwide Danish population-based study. Social Psychiatry and Psychiatric Epidemiology
Tsuang, MT, Tohen, M, Jones, PB (eds) (2011). Textbook of Psychiatric Epidemiology. John Wiley & Sons, Ltd: Chichester, UK.
Uggerby, P, Østergaard, SD, Røge, R, Correll, CU, Nielsen, J (2013). The validity of the schizophrenia diagnosis in the Danish Psychiatric Central Research Register is good. Danish Medical Journal